β-Asarone inhibits neuronal apoptosis via the CaMKII/CREB/Bcl-2 signaling pathway in an in vitro model and AβPP/PS1 mice

Journal of Alzheimer's Disease

Volumn 33, Issue 3, 2013, Pages 863-880

  Wei, Gang ^a   Chen, Yun Bo ^a   Chen, Dong Feng ^a   Lai, Xiao Ping ^a   Liu, Dong Hui ^a   Deng, Ru Dong ^a   Zhou, Jian Hong ^a   Zhang, Sai Xia ^a   Li, Yi Wei ^a   Lii, Hui ^a   Liu, Liu Fang ^a   Wang, Qi ^a   Nie, Hui ^a  

^a GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Alzheimer's disease; Bcl 2; CaMKII; neuronal apoptosis; phospho CREB binding protein; asarone

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; BETA ASARONE; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DONEPEZIL; PRESENILIN 1; PROTEIN BCL 2;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BRAIN CORTEX; CELL VIABILITY; COGNITION; CONTROLLED STUDY; DRUG INHIBITION; ENZYME INHIBITION; FLOW CYTOMETRY; GENE OVEREXPRESSION; IN VITRO STUDY; MOUSE; NERVE CELL; NERVE CELL CULTURE; NEUROPROTECTION; NONHUMAN; PC12 CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; WILD TYPE;

EID: 84872432234     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2012-120865     Document Type: Article

References (57)

1. Mattson MP, Magnus T (2006) Ageing and neuronal vulnerability. Nat Rev Neurosci 7, 278-294.
2. Basun H, Bogdanovic N, Ingelsson M, Almkvist O, N?aslund J, Axelman K, Bird TD, Nochlin D, Schellenberg GD, Wahlund LO, Lannfelt L (2008) Clinical and neuropathological features of the arctic APP gene mutation causing early-onset Alzheimer disease. Arch Neurol 65, 499-505. (Pubitemid 351549959)
3. Pereira C, Ferreiro E, Cardoso SM, de OliveiraCR(2004) Cell degeneration induced by amyloid-beta peptides: Implications for Alzheimer's disease. J Mol Neurosci 23, 97-104. (Pubitemid 41359192)
4. Stadelmann C, Deckwerth TL, Srinivasan A, Bancher C, Br?uck W, Jellinger K, Lassmann H (1999) Activation of caspase 3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease. Evidence for apoptotic cell death. Am J Pathol 155, 1459-1466.
5. Olariu A, Yamada K, Mamiya T, Hefco V, Nabeshima T (2002) Memory impairment induced by chronic intracerebroventricular infusion of beta-amyloid (1-40) involves down regulation of protein kinase C. Brain Res 957, 278-286. (Pubitemid 35356523)
6. Loo DT, Copani A, Pike CJ, Whittemore ER, Walencewicz AJ, Cotman CW (1993) Apoptosis is induced by -amyloid in cultured central nervous system neurons. Proc Natl Acad Sci U S A 90, 7951-7955. (Pubitemid 23260832)
7. Xu J, Chen S,Ku G, Ahmed SH, Xu J, Chen H, HsuCY(2001) Amyloid peptide-induced cerebral endothelial cell death involves mitochondrial dysfunction and caspase activation. J Cereb Blood Flow Metab 21, 702-710. (Pubitemid 32510458)
8. LeBlanc AC (2005) The role of apoptotic pathways in Alzheimer's disease neurodegeneration and cell death. Curr Alzheimer Res 2, 389-402. (Pubitemid 41277753)
9. Krantic S, Mechawar N, Reix S, Quirion R (2007) Apoptosisinducing factor: A matter of neuron life and death. Prog Neurobiol 81, 179-196. (Pubitemid 46282274)
10. Kitamura Y, Shimohama S, Kamoshima W, Ota T, Matsuoka Y, Nomura Y, Smith MA, Perry G, Whitehouse PJ, Taniguchi T (1998) Alteration of proteins regulating apoptosis, Bcl-2, Bcl-x, Bax, Bak, Bad, ICH-1 and CPP32, in Alzheimer's disease. Brain Res 780, 260-269. (Pubitemid 28082914)
11. Tamagno E, Parola M, Guglielmotto M, Santoro G, Bardini P, Marra L, Tabaton M, Danni O (2003) Multiple signaling events in amyloid beta-induced, oxidative stress-dependent neuronal apoptosis. Free Radic Biol Med 35, 45-58. (Pubitemid 36782336)
12. Sheng M, Hoogenraad CC (2007) The postsynaptic architecture of excitatory synapses: A more quantitative view. Annu Rev Biochem 76, 823-847.
13. MerrillMA,ChenY, Strack S, HellJW(2005) Activity-driven post synaptic translocation of CaMKII. Trends Pharmacol Sci 26, 645-653. (Pubitemid 41636310)
14. Yamauchi T (2005) Neuronal Ca2+/calmodulin-dependent protein kinase II - discovery, progress in a quarter of a century, and perspective: implication for learning and memory. Biol Pharm Bull 28, 1342-1354. (Pubitemid 41379679)
15. YoshimuraY, IchinoseT,YamauchiT(2003) Phosphorylation of tau protein to sites found in Alzheimer's disease brain is catalyzed by Ca2+/calmodulin- dependent protein kinase II as demonstrated tandem mass spectrometry. Neurosci Lett 353, 185-188. (Pubitemid 37510173)
16. van Woerden GM, Harris KD, Hojjati MR, Gustin RM, Qiu S, de Avila Freire R, Jiang YH, Elgersma Y, Weeber EJ (2007) Rescue of neurological deficits in a mouse model for Angelman syndrome by reduction of a CaMKII inhibitory phosphorylation. Nat Neurosci 10, 280-282.
17. Takano H, Fukushi H, Morishima Y, Shirasaki Y (2003) Calmodulin and calmodulin-dependent kinase II mediate neuronal cell death induced by depolarization. Brain Res 962, 41-47. (Pubitemid 36126320)
18. Yano S, Morioka M,Kuratsu J, FukunagaK(2005) Functional proteins involved in regulation of intracellular Ca2+ for drug development: Role of calcium/calmodulin-dependent protein kinases in ischemic neuronal death. J Pharmacol Sci 97, 351-354. (Pubitemid 40515750)
19. Fan W, Li X, Cooper NG (2007) Cambia alpha B mediates a survival response in retinal ganglion cells subjected to a glutamate stimulus. Invest Ophthalmol Vis Sci 48, 3854-3863. (Pubitemid 351261127)
20. Takeda H, Kitaoka Y, Hayashi Y, Kumai T, Munemasa Y, Fujino H, Kobayashi S, Ueno S (2007) Calcium/calmodulindependent protein kinase II regulates the phosphorylation of CREB in NMDA-induced retinal neurotoxicity. Brain Res 1184, 306-315. (Pubitemid 350160572)
21. Liao J-F, Huang S-Y, Jan Y-M, Yu L-L, Chen C-F (1998) Central inhibitory effects of water extract of Acori graminei rhizoma in mice. J Ethnopharmacol 61, 185-193. (Pubitemid 28342685)
22. Irie Y, Keung WM (2003) Rhizoma acori graminei and its active principles protect PC-12 cells from the toxic effect of amyloid-b peptide. Brain Res 963, 282-289. (Pubitemid 36126309)
23. Cho J, Joo NE, Kong JY, Jeong DY, Lee KD, Kang BS (2000) Inhibition of exitotoxic neuronal death by methanol extract of Acori graminei rhizoma in cultured rat cortical neusons. J Ethnopharmacol 73, 31-37.
24. Lee B, Choi Y, Kim H, Kim SY, Hahm DH, Lee HJ, Shim I (2003) Protective effects of methanol extract of Acori graminei rhizoma and Uncariae Ramulus et Uncus on ischemia-induced neuronal death and cognitive impairments in the rat. Life Sci 74, 435-450. (Pubitemid 37383732)
25. Zhang H, Han T, Yu CH, Rahman K, Qin LP, Peng C (2007) Ameliorating effects of essential oil from Acori graminei rhizoma on learning and memory in aged rats and mice. J Pharm Pharmacol 59, 301-309. (Pubitemid 46203068)
26. Liao WP, Chen L, Yi YH, SunWW, Gao MM, Su T, Yang SQ (2005) Study of antiepileptic effect of extracts from Acorus tatarinowii Schott. Epilepsia 46, 21-24. (Pubitemid 40365622)
27. Koo BS, Park KS, Ha JH, Park JH, Lim JC, Lee DU (2003) Inhibitory effects of the fragrance inhalation of essential oil from Acorus gramineus on central nervous system. Biol Pharm Bull 26, 978-982. (Pubitemid 41685423)
28. Zou DJ, Wang G, Liu JC, Dong MX, Li XM, Zhang C, Zhou L, Wang R, Niu YC (2011) Beta-asarone attenuates beta-amyloid-induced apoptosis through the inhibition of the activation of apoptosis signal-regulating kinase 1 inSH-SY5Y cells. Pharmazie 66, 44-51.
29. Li C, Xing G, Dong M, Zhou L, Li J, Wang G, Zou D, Wang R, Liu J, Niu Y (2010) Beta-asarone protection against beta-amyloid-induced neurotoxicity in PC12 cells via JNK signaling and modulation of Bcl-2 family proteins. Eur J Pharmacol 635, 96-102.
30. Geng Y, Li C, Liu J, Xing G, Zhou L, Dong M, Li X, Niu Y (2010) Beta-asarone improves cognitive function by suppressing neuronal apoptosis in the beta-amyloid hippocampus injection rats. Biol Pharm Bull 33, 836-843.
31. Jiang Y, Fang YQ, Li XB, Li L, Jiang HL (2007) Protective effect of -asarone on apoptosis of rat models with Alzheimer disease induce by amyloid-beta protein intra-hippocampal injection. Prog Modern Biomed 7, 1300-1302.
32. Lamb BT, Bardel KA, Kulnane LS, Anderson JJ, Holtz G, Wagner SL (1999) Amyloid production and deposition in mutant amyloid precursor protein and presenilin-1 yeast artificial chromosome transgenic mice. Nat Neurosci 2, 695-697.
33. Tatton WG, Chalmers-Redman RM, Ju WJ, Mammen M, Carlile GW, Pong AW, Tatton NA (2002) Propargylamines induce antiapoptotic new protein synthesis in serum- and nerve growth factor (NGF)-withdrawn, NGF-differentiated PC-12 cells. J Pharmacol Exp Ther 301, 753-764. (Pubitemid 34429993)
34. Xu Y, Traystman RJ, Hurn PD, Wang MM (2003) Neuritelocalized estrogen receptor-alpha mediates rapid signaling by estrogen. J Neurosci Res 74, 1-11. (Pubitemid 37176663)
35. Albrecht S, Bourdeau M, Bennett D, Mufson EJ, Bhattacharjee M, LeBlanc AC (2007) Activation of caspase-6 in aging and mild cognitive impairment. Am J Pathol 170, 1200-1209. (Pubitemid 47339328)
36. Wu CK, Thal L, Pizzo D, Hansen L, Masliah E, Geula C (2005) Apoptotic signals within the basal forebrain cholinergic neurons in Alzheimer's disease. Exp Neurol 195, 484-496. (Pubitemid 41297799)
37. Wei Z, Song MS, MacTavish D, Jhamandas JH, Kar S (2008) Role of calpain and caspase in beta-amyloid-induced cell death in rat primary septal cultured neurons. Neuropharmacology 54, 721-733.
38. Calissano P, Matrone C, Amadoro G (2009) Apoptosis and in vitro Alzheimer disease neuronal models. Commun Integr Biol 2, 163-169.
39. Ferreiro E, Oliveira C, PereiraC(2008) The release of calcium from the endoplasmic reticulum induced by amyloid-beta and prion peptides activates the mitochondrial apoptotic pathway. Neurobiol Dis 30, 331-342.
40. Bertram L, Tanzi RE (2008) Thirty years of Alzheimer's disease genetics: The implications of systematic meta-analyses. Nat Rev Neurosci 9, 768-778.
41. Kurt MA, Davies DC, Kidd M, Duff K, Rolph SC, Jennings KH (2001) Neurodegenerative changes associated with betaamyloid deposition in the brains of mice carrying mutant amyloid precursor protein and mutant presenilin-1 transgenes. Exp Neurol 171, 59-71. (Pubitemid 32848445)
42. Faure A, Verret L, Bozon B, El Tannir El Tayara N, Ly M, Kober F, Dhenain M, Rampon C, Delatour B (2011) Impaired neurogenesis, neuronal loss, and brain functional deficits in the APPxPS1-Ki mouse model of Alzheimer's disease. Neurobiol Aging 32, 407-418.
43. Goebel DJ (2009) Selective blockade of CaMKII- inhibits NMDA-induced caspase-3-dependent cell death but does not arrest PARP-1 activation or loss of plasma membrane selectivity in rat retinal neurons. Brain Res 1256, 190-204.
44. Gu Z, Liu W, Yan Z (2009) Beta-amyloid impairs AMPA receptor trafficking and function by reducing Ca2+/calmodulin-dependent protein kinase II synaptic distribution. J Biol Chem 284, 10639-10649.
45. Dosemeci A, Jaffe H (2010) Regulation of phosphorylation at the postsynaptic density during different activity states of Ca2+/calmodulin- dependent protein kinase II. Biochem Biophys Res Commun 391, 78-84.
46. Bok J, Wang Q, Huang J, Green SH (2007) CaMKII and CaMKIV mediate distinct prosurvival signaling pathways in response to depolarization in neurons. Mol Cell Neurosci 36, 13-26. (Pubitemid 47379552)
47. Srivareerat M, Tran TT, Alzoubi KH, Alkadhi KA (2009) Chronic psychosocial stress exacerbates impairment of cognition and long-term potentiation in beta-amyloid rat model of Alzheimer's disease. Biol Psychiatry 65, 918-926.
48. Kitagawa K (2007) CREB and cAMP response elementmediated gene expression in the ischemic brain. FEBS J 274, 3210-3217. (Pubitemid 47024985)
49. Lonze BE, GintyDD(2002) Function and regulation ofCREB family transcription factors in the nervous system. Neuron 35, 605-623. (Pubitemid 35229980)
50. Merry DE, Korsmeyer SJ (1997) Bcl-2 gene family in the nervous system. Annu Rev Neurosci 20, 245-267.
51. Ikezu T, Okamoto T, Komatsuzaki K, Matsui T, Martyn JA, Nishimoto I (1996) Negative transactivation of cAMP response element by familial Alzheimer's mutants of APP. EMBO 15, 2468-2475. (Pubitemid 26151186)
52. Fan W, Agarwal N, Cooper NG (2006) The role of CaMKII in BDNF-mediated neuroprotection of retinal ganglion cells (RGC-5). Brain Res 1067, 48-57. (Pubitemid 43133073)
53. Sevilla C, Jimenez Caballero PE, AlfonsoV, Gonzalez-Adalid M(2009) Current treatments of Alzheimer disease: Are main caregivers satisfied with the drug treatments received by their patients? Dement Geriatr Cogn Disord 28, 196-205.
54. Ginsberg MD (2008) Neuroprotection for ischemic stroke: Past, present and future. Neuropharmacology 55, 363-389.
55. Levy YS, Gilgun-SherkiY, Melamed E, OffenD(2005) Therapeutic potential of neurotrophic factors in neurodegenerative diseases. BioDrugs 19, 97-127. (Pubitemid 40559475)
56. Youdim MB, Buccafusco JJ (2005) CNS targets for multifunctional drugs in the treatment of Alzheimer's and Parkinson's diseases. J Neural Transm 112, 519-537. (Pubitemid 40562085)
57. Mukherjee PK, Kumar V, Mal M, Houghton PJ (2007) In vitro acetylcholinesterase inhibitory activity of the essential oil from Acorus calamus and its main constituents. Planta Med 73, 283-285. (Pubitemid 46917484)